These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9294172)

  • 21. Isolation of a tenascin-R binding protein from mouse brain membranes. A phosphacan-related chondroitin sulfate proteoglycan.
    Xiao ZC; Bartsch U; Margolis RK; Rougon G; Montag D; Schachner M
    J Biol Chem; 1997 Dec; 272(51):32092-101. PubMed ID: 9405406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Region and lamina-specific distribution of extracellular matrix proteoglycans, hyaluronan and tenascin-R in the mouse hippocampal formation.
    Brückner G; Grosche J; Hartlage-Rübsamen M; Schmidt S; Schachner M
    J Chem Neuroanat; 2003 Aug; 26(1):37-50. PubMed ID: 12954529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocan: a brain chondroitin sulfate proteoglycan.
    Rauch U; Feng K; Zhou XH
    Cell Mol Life Sci; 2001 Nov; 58(12-13):1842-56. PubMed ID: 11766883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular matrix components mark the territories of circumventricular organs.
    Pócsai K; Kálmán M
    Neurosci Lett; 2014 Apr; 566():36-41. PubMed ID: 24561092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex-type asparagine-linked oligosaccharides on phosphacan and protein-tyrosine phosphatase-zeta/beta mediate their binding to neural cell adhesion molecules and tenascin.
    Milev P; Meyer-Puttlitz B; Margolis RK; Margolis RU
    J Biol Chem; 1995 Oct; 270(42):24650-3. PubMed ID: 7559574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAG-1/axonin-1 is a high-affinity ligand of neurocan, phosphacan/protein-tyrosine phosphatase-zeta/beta, and N-CAM.
    Milev P; Maurel P; Häring M; Margolis RK; Margolis RU
    J Biol Chem; 1996 Jun; 271(26):15716-23. PubMed ID: 8663515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and binding activity of the carboxyl-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan.
    Ujita M; Shinomura T; Ito K; Kitagawa Y; Kimata K
    J Biol Chem; 1994 Nov; 269(44):27603-9. PubMed ID: 7961677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocan is a heparin binding proteoglycan.
    Feng K; Arnold-Ammer I; Rauch U
    Biochem Biophys Res Commun; 2000 Jun; 272(2):449-55. PubMed ID: 10833434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell surface glycosylphosphatidylinositol-anchored isoforms.
    Seidenbecher CI; Richter K; Rauch U; Fässler R; Garner CC; Gundelfinger ED
    J Biol Chem; 1995 Nov; 270(45):27206-12. PubMed ID: 7592978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brevican: a major proteoglycan in adult brain.
    Yamaguchi Y
    Perspect Dev Neurobiol; 1996; 3(4):307-17. PubMed ID: 9117262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Versican and brevican are expressed with distinct pathology in neonatal hypoxic-ischemic injury.
    Leonardo CC; Eakin AK; Ajmo JM; Gottschall PE
    J Neurosci Res; 2008 Apr; 86(5):1106-14. PubMed ID: 17972319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex.
    Mayer J; Hamel MG; Gottschall PE
    BMC Neurosci; 2005 Aug; 6():52. PubMed ID: 16122387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental changes in the biochemical and immunological characters of the carbohydrate moiety of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan.
    Shuo T; Aono S; Matsui F; Tokita Y; Maeda H; Shimada K; Oohira A
    Glycoconj J; 2004; 20(4):267-78. PubMed ID: 15115911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience-dependent development of perineuronal nets and chondroitin sulfate proteoglycan receptors in mouse visual cortex.
    Ye Q; Miao QL
    Matrix Biol; 2013 Aug; 32(6):352-63. PubMed ID: 23597636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif.
    Yang BL; Cao L; Kiani C; Lee V; Zhang Y; Adams ME; Yang BB
    J Biol Chem; 2000 Jul; 275(28):21255-61. PubMed ID: 10801813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility.
    Hu B; Kong LL; Matthews RT; Viapiano MS
    J Biol Chem; 2008 Sep; 283(36):24848-59. PubMed ID: 18611854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of versican with its binding partners.
    Wu YJ; La Pierre DP; Wu J; Yee AJ; Yang BB
    Cell Res; 2005 Jul; 15(7):483-94. PubMed ID: 16045811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphology of perineuronal nets in tenascin-R and parvalbumin single and double knockout mice.
    Haunsø A; Ibrahim M; Bartsch U; Letiembre M; Celio MR; Menoud P
    Brain Res; 2000 May; 864(1):142-5. PubMed ID: 10793198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan.
    Tompson SW; Merriman B; Funari VA; Fresquet M; Lachman RS; Rimoin DL; Nelson SF; Briggs MD; Cohn DH; Krakow D
    Am J Hum Genet; 2009 Jan; 84(1):72-9. PubMed ID: 19110214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenascin-contactin/F11 interactions: a clue for a developmental role?
    Vaughan L; Weber P; D'Alessandri L; Zisch AH; Winterhalter KH
    Perspect Dev Neurobiol; 1994; 2(1):43-52. PubMed ID: 7530143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.